Bringing the fundamentals into focus…
Back to Solventum Corporation
How Solventum Corporation stacks up
SOLV · against 1,336 other Healthcare companies
Valuation
92/ 100
Near the top of its peers.
Ranked #102 of 1,337 · scores higher than 92% of peers
Bars: peers in each 10-point band of the valuation score141 peers with a valuation score of 90–100, including SOLV · Click a bar to see the companies
Why valuation scores 92?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield, which is stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -0.8% vs peer median 0.0%
- EBITDA yield is close to the peer norm. EBITDA yield: 13.5% vs peer median 4.0%
- higher earnings for the price paid: stronger than 95% of peers. Earnings yield: 9.9% vs peer median 1.5%
Metric by metric
Position: dot = SOLV, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SOLV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 9.7% | 1.5% | 95% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 5.9% | 4.2% | 60% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | -0.8% | -1.0% | 51% | 20% | |
| Book yieldHigher is better · 1,306 reported | 33.3% | 37.9% | 44% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around SOLVScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score